The role of new biomarkers for the diagnosis and treatment of colon cancer

• Authors: Magdalena Czarnecka-Czapczyńska , Dorota Bartusik-Aebisher , Magdalena Krupka-Olek , David Aebisher , Grzegorz Cieślar , Wojciech Latos , Aleksandra Kawczyk-Krupka

Abstracts

EN

Introduction. Colorectal cancer may be benign or malignant. According to the World Health Organization and CDC, it is the second most common cancer worldwide, after lung cancer. The mortality of colorectal cancer has been dropping for more than 20 years due to the improvements in screening techniques and treatments. Aim. The aim of this article is to discuss the role of new biomarkers for the diagnosis and treatment of colon cancer. Material and methods. This article is a review done in regards to discuss the role of new biomarkers for the diagnosis and treatment of colon cancer. Analysis of the literature. A review is discussed the role of new biomarkers for the diagnosis and treatment of colon cancer using current literature. Conclusion. The screening tests based on diagnostic new biomarkers may cause faster detection of cancer and risk factors, and provide prognostic information in order to adjust individual therapy.

Keywords

EN

colon cancer; diagnosis; treatment

• Publisher: Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
• Journal: European Journal of Clinical and Experimental Medicine
• Year: 2021
• Issue: 4
• Pages: 326-329

Dates

published

2021

Contributors

author

Magdalena Czarnecka-Czapczyńska

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

author

Dorota Bartusik-Aebisher

• Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszów, University of Rzeszów, Rzeszów, Poland

author

Magdalena Krupka-Olek

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland
• Clinical Department of Internal Medicine, Dermatology and Allergology, Medical University of Silesia, Katowice, Zabrze, Poland

author

David Aebisher

• Department of Biochemistry and General Chemistry, Medical College of the University of Rzeszów, University of Rzeszów, Rzeszów, Poland

author

Grzegorz Cieślar

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

author

Wojciech Latos

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

author

Aleksandra Kawczyk-Krupka

• Department of Internal Medicine, Angiology and Physical Medicine, Centre for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Bytom, Poland

Identifiers

DOI

10.15584/ejcem.2021.4.7

Biblioteka Nauki

2040510